Cargando…
Downregulation of dual‐specificity tyrosine‐regulated kinase 2 promotes tumor cell proliferation and invasion by enhancing cyclin‐dependent kinase 14 expression in breast cancer
Tumor progression is the main cause of death in patients with breast cancer. Accumulating evidence suggests that dual‐specificity tyrosine‐regulated kinase 2 (DYRK2) functions as a tumor suppressor by regulating cell survival, differentiation, proliferation and apoptosis. However, little is known ab...
Autores principales: | Imawari, Yoshimi, Mimoto, Rei, Hirooka, Shinichi, Morikawa, Toshiaki, Takeyama, Hiroshi, Yoshida, Kiyotsugu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5797831/ https://www.ncbi.nlm.nih.gov/pubmed/29193658 http://dx.doi.org/10.1111/cas.13459 |
Ejemplares similares
-
Dual‐specificity tyrosine‐regulated kinase 2 is a suppressor and potential prognostic marker for liver metastasis of colorectal cancer
por: Ito, Daisuke, et al.
Publicado: (2017) -
Clinical implications of drug-screening assay for recurrent metastatic hormone receptor-positive, human epidermal receptor 2-negative breast cancer using conditionally reprogrammed cells
por: Mimoto, Rei, et al.
Publicado: (2019) -
Enforced dual‐specificity tyrosine‐regulated kinase 2 expression by adenovirus‐mediated gene transfer inhibits tumor growth and metastasis of colorectal cancer
por: Imaizumi, Yuta, et al.
Publicado: (2022) -
MicroRNA-495 inhibits proliferation of glioblastoma multiforme cells by downregulating cyclin-dependent kinase 6
por: Chen, Shu-Mei, et al.
Publicado: (2013) -
Cyclin-dependent kinases
por: Malumbres, Marcos
Publicado: (2014)